10.4244/EIJV9I5A90
•
Sep 27, 2013
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y, Zhong S-L
free
10.4244/EIJV9I5A93
•
Sep 27, 2013
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S
free
10.4244/EIJV9I5A94
•
Sep 27, 2013
A new methodology for accurate 3-dimensional coronary artery reconstruction using routine intravascular ultrasound and angiographic data: implications for widespread assessment of endothelial shear stress in humans
Bourantas C, Papafaklis M, Athanasiou L, Kalatzis F, Naka K, Siogkas P, Takahashi S, Saito S, Fotiadis D, Feldman C, Stone P, Michalis L
free
10.4244/EIJV9I5A96
•
Sep 27, 2013
Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography
Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S
free
10.4244/EIJV9I5A99
•
Sep 27, 2013
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Borger MA, Degenhardt R, Scheller B
free
10.4244/EIJV9I5A100
•
Sep 27, 2013
Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale
Freixa X, Ibrahim R, Chan J, Garceau P, Dore A, Marcotte F, Mercier L-A, Pierre-Mongeon F, Basmadjian A, Khairy P, Asgar A
free
